"Muscle Spasticity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a "free interval") followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54)
| Descriptor ID |
D009128
|
| MeSH Number(s) |
C05.651.512 C10.597.613.550.550 C23.888.592.608.550.550
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Muscle Spasticity".
Below are MeSH descriptors whose meaning is more specific than "Muscle Spasticity".
This graph shows the total number of publications written about "Muscle Spasticity" by people in this website by year, and whether "Muscle Spasticity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 9 | 3 | 12 |
| 2018 | 6 | 1 | 7 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Muscle Spasticity" by people in Profiles.
-
How Did the Lockdown Imposed Due to COVID-19 Affect Patients With Cerebral Palsy? Pediatr Phys Ther. 2021 10 01; 33(4):246-249.
-
Anatomical locations of the motor endplates of sartorius muscle for botulinum toxin injections in treatment of muscle spasticity. Surg Radiol Anat. 2021 Dec; 43(12):2025-2030.
-
Consensus recommendations for botulinum toxin injections in the spasticity management of children with cerebral palsy during COVID-19 outbreak Turk J Med Sci. 2021 04 30; 51(2):385-392.
-
Atypical cutaneous and musculoskeletal manifestation of SARS-CoV-2: 'COVID-19 toes' and spasticity in a 48-year-old woman. BMJ Case Rep. 2021 Mar 17; 14(3).
-
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity. Eur J Phys Rehabil Med. 2021 Jun; 57(3):424-433.
-
Spasticity Outpatient Evaluation via Telemedicine: A Practical Framework. Am J Phys Med Rehabil. 2020 12; 99(12):1086-1091.
-
Impact of COVID-19 on neurological patients attending a botulinum toxin service. Neurol Sci. 2021 02; 42(2):433-435.
-
Practical Guidance for Outpatient Spasticity Management During the Coronavirus (COVID-19) Pandemic: Canadian Spasticity COVID-19 Task Force. Can J Neurol Sci. 2020 09; 47(5):589-593.
-
Pediatric intrathecal baclofen management during the COVID-19 pandemic in the US and Canada. J Pediatr Rehabil Med. 2020; 13(3):379-384.
-
Botulinum Toxin Type A and Physiotherapy in Spasticity of the Lower Limbs Due to Amyotrophic Lateral Sclerosis. Toxins (Basel). 2019 07 01; 11(7).